Clover Health Investments has been granted a patent for a system that generates document content through data analysis. The system interacts with electronic devices to collect user input, evaluates the information against a scoring threshold, and iteratively refines document fields to assist in determining patient diagnoses. GlobalData’s report on Clover Health Investments gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Clover Health Investments, Treatment response prediction was a key innovation area identified from patents. Clover Health Investments's grant share as of June 2024 was 36%. Grant share is based on the ratio of number of grants to total number of patents.
Document generation and analysis for patient diagnosis information
The patent US11983947B2 describes a computing device designed to facilitate the diagnosis process for patients by utilizing a structured document-based approach. The device comprises one or more processors and non-transitory computer-readable media that store instructions for executing specific operations. These operations include sending a document to an electronic device, which contains fields for requesting information related to a patient's diagnosis. The device evaluates the received information by calculating a score that indicates the likelihood of a diagnosis based on the provided data. If the score does not meet a predetermined threshold, the device prompts for additional information by modifying the document to include a second field. This iterative process continues until sufficient information is gathered to either confirm a diagnosis or determine the need for further inquiry.
Additionally, the patent outlines various enhancements to the basic operations, such as the ability to store rules that associate different fields of information, the generation of reports summarizing the diagnostic process, and the capability to adapt the document based on user type or the timing of responses. The system can also alter the questions posed in the document based on the elapsed time since the last interaction, ensuring that the inquiry remains relevant and targeted. Ultimately, the patent emphasizes a systematic approach to gathering and evaluating diagnostic information, which can lead to more accurate and timely patient assessments.
To know more about GlobalData’s detailed insights on Clover Health Investments, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
